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Background
Pattern recognition receptors from the Toll-like receptor
(TLR) family are pivotal components of innate immu-
nity, and have been shown to contribute to colon cancer
formation. However, the molecular and cellular mechan-
isms underlying TLR-signaling in colon cancer remain
unclear. The adapter protein Myeloid-differentiation
factor 88 (MyD88) is shared between several TLRs and
the Interleukin-1 receptor family. MyD88-deficiency
protects mice from intestinal cancer formation in
genetic models for colon cancer. The genetic mouse
model presented here allows tissue-specific expression
of MyD88, and thereby the dissection of the complex
interaction between tumour and immune system during
intestinal carcinogenesis.
Material and methods
Insertion of an ‘intron-gene-trap’ flanked with loxP
motifs into the first intron of the MyD88 gene locus
leads to global inactivation of myD88 expression
(MyD88LSL), faithfully phenotyping a global gene knock-
out. Tissue-specific re-expression of MyD88 in mice is
mediated based on the Cre-recombinase. Breeding of
MyD88LSL mice with LysMCre or pvillin-Cre mice leads
to tissue-specific excision of the ‘intron-gene-trap’,
retaining endogenous regulation of gene expression.
MyD88 expression and successful reconstitution of
TLR-signaling was detected in either myeloid cells
(MyD88MYEL) or intestinal epithelial cells (MyD88IEC).
Subsequently, these animals were mated with Apc1638N/+
mice, an established genetic mouse model for human
colon cancer.
Results
Global MyD88 deficiency dramatically decreased tumour
incidence and aggressiveness in Apc1638N/+ mice.
Re-expression of MyD88 in intestinal epithelial cells
only partially restored tumor formation. On the other
hand, reconstitution of MyD88 expression in myeloid
cells triggered tumour development virtually indistin-
guishable from parental Apc1638N/+ mice. Activation of
the canonical Wnt signaling pathway, induced by loss of
function of Apc, was independent of MyD88. In con-
trast, MyD88 expression was required for full activation
of MAPK/ERK signaling in intestinal epithelial cells.
Furthermore, our results suggest a pro-tumorigenic
function for the pro-inflammatory cytokines IL-1beta
and IL-6, which were produced in a MyD88-dependent
fashion by myeloid cells.
Conclusions
MyD88-mediated signaling has pro-tumorigenic effects
in both IECs and in myeloid cells, but via different
mechanisms. Moreover, MyD88 function in myeloid
cells is crucial for intestinal tumour development, and
its inhibition may form a promising therapeutic strategy.
Published: 12 March 2014
doi:10.1186/2051-1426-2-S2-P6
Cite this article as: Holtorf et al.: P15. A genetic mouse model to
identify the role of the immune adapter protein MyD88 in colorectal
cancer. Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):P6.
Klinikum rechts der Isar, Chirurgische Klinik und Poliklinik, Munich, Germany
Holtorf et al. Journal for ImmunoTherapy of Cancer 2014, 2(Suppl 2):P6
http://www.immunotherapyofcancer.org/content/2/S2/P6
© 2014 Holtorf et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
